Biotech - Press Releases

Date	Title	Company
16-Dec-2019	HOYA Group PENTAX Medical Cleared CE Mark for DISCOVERY(TM), an AI Assisted Polyp Detector	HOYA Corporation PENTAX Medical
13-Dec-2019	FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups	U.S. Food and Drug Administration
13-Dec-2019	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PTC Therapeutics, Inc.
13-Dec-2019	FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system	U.S. Food and Drug Administration
13-Dec-2019	CGT Catapult hosts second annual workshop to address digital challenges in adoption of advanced therapies by the NHS	Advanced Therapy Medicinal Products (ATMPs) are
13-Dec-2019	UKI2S, CATAPULT VENTURES AND JONATHAN MILNER INVEST £500K IN GENE MODULATION NEWCOMER PENCIL BIOSCIENCES	: UK Innovation & Science Seed Fund
13-Dec-2019	OXGENE™ announces year of continued growth and first licensing deals in Asia	OXGENE™
13-Dec-2019	All haemophilia A patients in Republic of Ireland get continued access to Sobi’s extended half-life factor replacement therapy	Sobi
13-Dec-2019	Emergex Completes First Step in the Development of a Vaccine Candidate Against Intracellular Bacterium and Bioterrorist Agent Francisella Tularensis	Emergex Vaccines Holding Limited
13-Dec-2019	NICE AND THE SMC HAVE PUBLISHED RECOMMENDATIONS ON SHIONOGI’S MULPLEO® (LUSUTROMBOPAG), APPROVING ITS USE FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES	Shionogi & Co., Ltd
13-Dec-2019	Almirall and Iktos announce research collaboration in Artificial Intelligence for new drug design	Almirall, S.A. (ALM)
13-Dec-2019	Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015	Moberg Pharma AB
13-Dec-2019	Nordic Nanovector provides update on LYMRIT 37-05 Phase 1 DLBCL trial	Nordic Nanovector ASA
13-Dec-2019	PureTech Affiliate Akili Announces AKL-T03 Achieved Primary Endpoint, Improving Cognitive Impairments in Major Depressive Disorder Trial	PureTech Health plc
13-Dec-2019	Transgene Reports on the Combination Trial of TG4010, Chemotherapy and Nivolumab in Non-Small Cell Lung Cancer	Transgene
13-Dec-2019	BioLineRx Announces Updated Phase 2a Data From Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer	BioLineRx Ltd.
13-Dec-2019	ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir (DTG) for children living with HIV	ViiV Healthcare
13-Dec-2019	Hansa Biopharma has agreed with the FDA on a regulatory path forward for imlifidase in kidney transplantation of highly sensitized patients in the U.S.	Hansa Biopharma
13-Dec-2019	CHMP Issues Positive Opinion to Expand CYRAMZA® (ramucirumab) Label to Include Results from RELAY Study in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer	Eli Lilly and Company
13-Dec-2019	Anixa Biosciences Provides Update on CAR-T Program	Anixa Biosciences, Inc.